- Home
- GANX vs USIO Comparison
GANX vs USIO Comparison
Compare GANX & USIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- USIO
- Stock Information
- Founded
- GANX 2017
- USIO 1998
- Country
- GANX United States
- USIO United States
- Employees
- GANX N/A
- USIO N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- USIO Investment Bankers/Brokers/Service
- Sector
- GANX Health Care
- USIO Finance
- Exchange
- GANX Nasdaq
- USIO Nasdaq
- Market Cap
- GANX 53.8M
- USIO 37.1M
- IPO Year
- GANX 2021
- USIO N/A
- Fundamental
- Price
- GANX $1.72
- USIO $1.76
- Analyst Decision
- GANX Strong Buy
- USIO Strong Buy
- Analyst Count
- GANX 5
- USIO 1
- Target Price
- GANX $8.20
- USIO $4.00
- AVG Volume (30 Days)
- GANX 305.2K
- USIO 106.9K
- Earning Date
- GANX 08-07-2025
- USIO 08-13-2025
- Dividend Yield
- GANX N/A
- USIO N/A
- EPS Growth
- GANX N/A
- USIO N/A
- EPS
- GANX N/A
- USIO 0.12
- Revenue
- GANX N/A
- USIO $83,970,504.00
- Revenue This Year
- GANX N/A
- USIO $16.33
- Revenue Next Year
- GANX N/A
- USIO $14.56
- P/E Ratio
- GANX N/A
- USIO $15.38
- Revenue Growth
- GANX N/A
- USIO 0.46
- 52 Week Low
- GANX $0.89
- USIO $1.24
- 52 Week High
- GANX $3.19
- USIO $2.92
- Technical
- Relative Strength Index (RSI)
- GANX 49.29
- USIO 69.34
- Support Level
- GANX $1.55
- USIO $1.55
- Resistance Level
- GANX $1.79
- USIO $1.69
- Average True Range (ATR)
- GANX 0.16
- USIO 0.09
- MACD
- GANX -0.00
- USIO 0.02
- Stochastic Oscillator
- GANX 44.53
- USIO 89.19
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About USIO Usio Inc.
Usio Inc is a United States-based company that provides integrated electronic payment services, including credit and debit card-based processing services and transaction processing via the Automated Clearing House, or ACH network to billers and retailers. The Company also has an additional wholly-owned subsidiary, which is the entity for Output Solutions operations.